A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy

NCT05582395 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

580

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiomyopathy, Hypertrophic

Interventions

DRUG: Mavacamten
OTHER: Placebo

Sponsor

Bristol-Myers Squibb